Searching…
CRISPR-P 2.0 is an improved version of CRISPR-P, which can design sgRNA for various CRISPR-Cas systems and plant genomes. It provides scoring systems, analysis functions and custom sequences for efficient and specific...
Non-canonical CRISPR systems adaptation has led to genome editing through nucleases, and the development of transcriptional and epigenetic regulation, transcriptome editing, and molecular diagnostics has resulted in a...
Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.
Unlike CRISPR 1.0, which hacks through DNA, CRISPR2.0 is capable of surgical incisions, making it suitable for a broader range of gene therapy applications.
A decade ago, CRISPR revolutionized the field of genetics and gave scientists a powerful new tool to manipulate DNA with speed, accuracy, and relative ease.
Few technologies have captured the imagination of the life sciences community as profoundly as CRISPR. What began as a bacterial defence mechanism against...
CRISPR, which stands for "clustered, regularly interspaced, short palindromic repeats," is an exciting technology that is catalyzing new advances in human and animal health. Adapted from nature, CRISPR is capable of a...
Explore CRISPR2.0 innovations in 2025—safer, faster, and more precise gene editing transforming healthcare, agriculture, and the environment globally.
History was made this year when the first FDA-approved CRISPR-based gene editing therapy became available to patients, designed to cure sickle cell anemia. That represents ground-breaking progress, but the treatment i...
Non-canonical CRISPR systems adaptation has led to genome editing through nucleases, and the development of transcriptional and epigenetic regulation, transcriptome editing, and molecular diagnostics has resulted in a...
